Meta AnalysisID 7707
125I粒子联合冷冻消融治疗晚期非小细胞肺癌的随机对照试验的Meta分析
CRD42023451900
Are 125I particles combined with cryoablation better for advanced non-small cell lung cancer?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7707
- Evidence Id
- 16265
- Core Evidence Id
- 16265
- Source Meta Analysis Id
- 7701
- Herb2 Meta Analysis Id
- HBMA007701
- Crd Id
- CRD42023451900
- Title
- Meta-analysis of a randomized controlled trial of 125I particles combined with cryoablation for advanced non-small cell lung cancer
- Review Question
- Are 125I particles combined with cryoablation better for advanced non-small cell lung cancer?
- Study Type Included
- randomized controlled trial, RCT
- Condition Being Studied
- Lung cancer is one of the most common malignant tumors in the world, and it has become the No. 1 cause of death from malignant tumors among urban population in China. Non-small cell lung cancer includes squamous cell carcinoma (squamous carcinoma), adenocarcinoma, and large cell carcinoma. Compared with small cell carcinoma, the growth and division of its cancer cells are slower and its metastasis is relatively late. Non-small cell lung cancer accounts for about 80% of all lung cancers, and about 75% of patients are already in the middle or late stage when they are found, with a very low 5-year survival rate.
- Participant
- 1 Only randomized controlled clinical studies, blinded or unblinded, were included in this study; 2 Diagnosis of NSCLC by histology or pathology; and 2 The diagnosis of NSCLC was confirmed by histology or pathology. 3 TNM stage IIb-IV non-small cell lung cancer according to the 7th edition of the AJCC 2010; 4 Age greater than 18 years. 4 Age greater than 18 years.
- Animal
- Human Disease Modelled
- Intervention
- 125I particles combined with cryoablation
- Comparator Control
- cryoablation
- Main Outcome
- 1 objective response rate，ORR 2 1-year survival rate Measures of effect
- Outcome Measure
- Additional Outcome
- 1 disease control rate，DCR 2 overall survival，OS 3 progression free survival，PFS
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Carcinoma, Non-Small-Cell Lung; Cryosurgery; Humans; Iodine Radioisotopes; Iodine-125; Lung Neoplasms
- Contact
- hanming yu [email protected]
- Organisational Affiliation
- The fourth Affiliated Hospital of Chinese medicine University
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-08-05
- Registration Date
- 2023-08-17
- Anticipated Start Date
- 2023-08-12
- Anticipated Completion Date
- 2023-11-18
- Title Cn
- 125I粒子联合冷冻消融治疗晚期非小细胞肺癌的随机对照试验的Meta分析
- Title En
- Meta-analysis of a randomized controlled trial of 125I particles combined with cryoablation for advanced non-small cell lung cancer
- Bilingual Status
- complete